Results 181 to 190 of about 898,423 (293)

<i>Candidatus</i> Liberibacter asiaticus encodes a functional BolA transcriptional regulator related to motility, biofilm development, and stress response. [PDF]

Front Microbiol
Zhan X, Huang G, Su J, Zhang J, Huang Q, Deng X, Xu M.   +6 more
europepmc   +1 more source

Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation.

Proceedings of the National Academy of Sciences of the United States of America, 2000
A. Poltorak, P. Ricciardi-Castagnoli, S. Citterio, B. Beutler   +3 more
semanticscholar   +1 more source

Hospital Readmission After Traumatic Brain Injury Hospitalization in Community‐Dwelling Older Adults

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To examine the risk of hospital readmission after an index hospitalization for TBI in older adults. Methods Using data from the Atherosclerosis Risk in Communities (ARIC) study, we used propensity score matching of individuals with an index TBI‐related hospitalization to individuals with (1) non‐TBI hospitalizations (primary analysis)
Rachel Thomas, Connor A. Law, Joan A. Casey, Thomas Mosley, Rebecca F. Gottesman, Ramon Diaz‐Arrastia, Holly Elser, Andrea L. C. Schneider   +7 more
wiley   +1 more source

CEPR1 function across plant lineages: peptide hormone recognition by cereal crop orthologs and developmental roles in barley. [PDF]

J Exp Bot
Taylor K, Dixon R, Taleski M, Hintzsche J, Aldiss Z, Massel K, Robinson H, Gagliardini V, Grossniklaus U, Godwin I, Hickey L, Djordjevic MA.   +11 more
europepmc   +1 more source

Discovery and Targeted Proteomic Studies Reveal Striatal Markers Validated for Huntington's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Clinical trials for Huntington's disease (HD) enrolling persons before clinical motor diagnosis (CMD) lack validated biomarkers. This study aimed to conduct an unbiased discovery analysis and a targeted examination of proteomic biomarkers scrutinized by clinical validation. Methods Cerebrospinal fluid was obtained from PREDICT‐HD and
Daniel Chelsky, Cara Joyce, H. Jeremy Bockholt, Paul A. Rudnick, William H. Adams, Fiona McAllister, Justin W. Smock, Michael A. Newton, Jane S. Paulsen   +8 more
wiley   +1 more source

Fanconi anemia complementation group C gene (FANCC) association with hereditary and sporadic renal tumors. [PDF]

Oncologist
Desai D, Sager RA, Basin M, Jacob JM, Morris GJ, Spiess PE, Li R, Cheng L, Necchi A, Kamat AM, Grivas P, Pavlick D, Goldberg H, Mollapour M, Lin D, Ross JS, Bratslavsky G, Basnet A, Daneshvar MA.   +18 more
europepmc   +1 more source

Glymphatic Dysfunction Reflects Post‐Concussion Symptoms: Changes Within 1 Month and After 3 Months

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Mild traumatic brain injury (mTBI) may alter glymphatic function; however, its progression and variability remain obscure. This study examined glymphatic function following mTBI within 1 month and after 3 months post‐injury to determine whether variations in glymphatic function are associated with post‐traumatic symptom severity ...
Eunkyung Kim, Han Gil Seo, Roh‐Eul Yoo, Byung‐Mo Oh   +3 more
wiley   +1 more source

Areca palm velarivirus 1 encoded CP suppresses antiviral RNA silencing by mediating the autophagic degradation of SGS3 and disrupting the SGS3-RDR6 interaction. [PDF]

Stress Biol
Wen J, Li H, Li Z, Wang H, Cao X, Huang X.   +5 more
europepmc   +1 more source

Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals.

Proceedings of the National Academy of Sciences of the United States of America, 2004
K. Luker, Matthew C. P. Smith, G. Luker, S. Gammon, H. Piwnica-Worms, D. Piwnica-Worms   +5 more
semanticscholar   +1 more source

In‐Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia Gravis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin, Liu Dong, Ying Wang, Dingxian He, Chong Yan, Jianying Xi, Haoqin Jiang, Yu Shi, Ming Guan, Chongbo Zhao, Jie Song, Sushan Luo   +11 more
wiley   +1 more source